Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cancer cell survival is dependent on oxidative-stress defenses against reactive oxygen species (ROS) that accumulate during tumorigenesis. Here, we show a non-canonical oxidative-stress defense mechanism through TRPA1, a neuronal redox-sensing Ca2+-influx channel. In TRPA1-enriched breast and lung cancer spheroids, TRPA1 is critical for survival of inner cells that exhibit ROS accumulation. Moreover, TRPA1 promotes resistance to ROS-producing chemotherapies, and TRPA1 inhibition suppresses xenograft tumor growth and enhances chemosensitivity. TRPA1 does not affect redox status but upregulates Ca2+-dependent anti-apoptotic pathways. NRF2, an oxidant-defense transcription factor, directly controls TRPA1 expression, thus providing an orthogonal mechanism for protection against oxidative stress together with canonical ROS-neutralizing mechanisms. These findings reveal an oxidative-stress defense program involving TRPA1 that could be exploited for targeted cancer therapies.
Pubmed ID: 29805077
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets S6 Ribosomal Protein
View all literature mentionsThis monoclonal targets Ptk2b
View all literature mentionsThis polyclonal targets 4 Hydroxynonenal antibody
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis polyclonal targets Phospho-Src Family (Tyr416)
View all literature mentionsThis polyclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis polyclonal targets TRPA1
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis monoclonal targets RPSA
View all literature mentionsThis monoclonal targets 4E-BP1 (53H11) Rabbit mAb
View all literature mentionsThis polyclonal targets Phospho-4E-BP1 (Ser65)
View all literature mentionsThis polyclonal targets Phospho-Pyk2 (Tyr402)
View all literature mentionsThis monoclonal targets Phospho-Akt (Thr308) (244F9) Rabbit mAb
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets 8-Hydroxy-2'-deoxyguanosine
View all literature mentionsThis monoclonal targets Akt (pan) (40D4) Mouse mAb
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis monoclonal targets Mcl-1 (D35A5) Rabbit mAb
View all literature mentionsThis polyclonal targets TRPA1 antibody produced in rabbit
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis unknown targets Src
View all literature mentionsCell line NCI-H1792 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line sNF96.2 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line NCI-H23 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line NCI-H647 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line A-549 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions